| Dr James L Reeder Sr, MD | |
|
1310 Somerville Rd Se, Decatur, AL 35601-4317 | |
| (256) 350-2550 | |
| (256) 350-9739 |
| Full Name | Dr James L Reeder Sr |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 1310 Somerville Rd Se, Decatur, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972588648 | NPI | - | NPPES |
| 81764 | Other | AL | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 1560 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr James L Reeder Sr, MD 1310 Somerville Rd Se, Decatur, AL 35601-4317 Ph: (256) 350-2550 | Dr James L Reeder Sr, MD 1310 Somerville Rd Se, Decatur, AL 35601-4317 Ph: (256) 350-2550 |
News Archive
Oxford Finance Corporation, a subsidiary of Sumitomo Corporation, today announced that it was the lead lender for a $30 million credit facility provided to Cadence Pharmaceuticals. Silicon Valley Bank and GE Financial Services, Inc. also participated in the loan agreement. This infusion of capital will support the company's potential launch of their investigational product candidate, OFIRMEV™, an intravenous formulation of acetaminophen that is currently marketed in Europe for the treatment of acute pain and fever.
Steroid therapy is commonly used to treat acute attacks of the inflammatory bowel diseases ulcerative colitis and Crohn's disease; however, because it does not provide long-term benefits and it carries a risk of serious side effects, it should not be used to treat inflammatory bowel disease for more than three months.
About 24,000 people are killed by lightning every year, with about 10 times as many people injured. The Wilderness Medical Society has issued important new practice guidelines for precautions that can lower the likelihood of being killed or injured and recommendations for effective medical treatments post-strike.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that more than two-thirds of surveyed gastroenterologists selected Centocor Ortho Biotech/Merck & Co./Mitsubishi Tanabe's Remicade as the most efficacious therapy for Crohn's disease, when compared to other currently available agents.
A new study has been released on the bioRxiv* preprint server, which deals with a comprehensive survey on alternative splicing concerning SARS-CoV-2 infection. This study has also included two other betacoronavirurses (SARS-CoV and MERS), a control set of unrelated viruses, and a bacterium, namely, Streptococcus pneumonia. The study findings suggest that several cellular parameters are affected owing to a betacoronavirus infection, which in turn affects some genes and invariably various biological functions.
› Verified 3 days ago
Jere H Weaver, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 722 Bank St Ne, Decatur, AL 35601 Phone: 256-351-1874 Fax: 256-351-1876 | |
Dr. Joseph Thomas Backe, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1203 Medical Dr Se, Decatur, AL 35601 Phone: 256-350-2875 Fax: 256-350-6228 | |
Samantha S Wyatt, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 620 Walnut St Ne, Suite A, Decatur, AL 35601 Phone: 256-353-7775 Fax: 256-353-7765 |